SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Comparison between the EQ-5D-5L and the EQ-5D-3L in patients with hepatitis B · Study

ArticleShelves

ArticleComparison between the EQ-5D-5L and the EQ-5D-3L in patients with hepatitis B

Yuanxi Jia2014

Article2014

Comparison between the EQ-5D-5L and the EQ-5D-3L in patients with hepatitis B

Yuanxi Jia · Fuqiang Cui · D. L. Zhang · G. M Zhang · F. Z. Wang · Ning Miao +3 more

90 citations·0/0 files stored·Quality of Life Research

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Health Systems, Economic Evaluations, Quality of Life Economic and Environmental Valuation Health Education and Validation

Abstract

No abstract was published for this record.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 90 citations exist upstream.

References

2012Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value Sets 2012Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study 2000Quality of Life 2002Estimating an EQ‐5D population value set: the case of Japan 1999A review of the use of health status measures in economic evaluation.2007Comparing the Standard EQ-5D Three-Level System with a Five-Level Version 2007Psychometric Comparison of the Standard EQ-5D to a 5 Level Version in Cancer Patients 2010Population health status in China: EQ-5D results, by age, sex and socio-economic status, from the National Health Services Survey 2008

Cited by

2014The EQ-5D-5L index score is more discriminative than the EQ-5D-3L index score in diabetes patients 2018Comparing the validity and responsiveness of the EQ-5D-5L to the Oxford hip and knee scores and SF-12 in osteoarthritis patients 1 year following total joint replacement 2017Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients 2016Comparing the performance of the EQ-5D-3L and the EQ-5D-5L in young Portuguese adults

Related works

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

2014The EQ-5D-5L index score is more discriminative than the EQ-5D-3L index score in diabetes patientsarticle · 9 shared references 2015Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patientsarticle · 7 shared references 2016Validation and comparison of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in Greecearticle · 7 shared references 2018Comparing the validity and responsiveness of the EQ-5D-5L to the Oxford hip and knee scores and SF-12 in osteoarthritis patients 1 year following total joint replacementarticle · 6 shared references 2017Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patientsarticle · 6 shared references 2016Comparing the performance of the EQ-5D-3L and the EQ-5D-5L in young Portuguese adultsarticle · 6 shared references

Details

Year2014

Typearticle

Published2014-03-13

VenueQuality of Life Research

ISSN-L0962-9343

Languageen

Citations90

Files0 public / 0

ShelfHealth Systems, Economic Evaluations, Quality of Life

Identifiers

doi10.1007/s11136-014-0670-3

openalex_workW2010837930

Links

Imported from OpenAlex (CC0) — nothing here is generated.

2018

Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn’s disease

2017The impact of influenza on the health related quality of life in China: an EQ-5D survey

2014The EQ-5D-5L Improves on the EQ-5D-3L for Health-related Quality-of-life Assessment in Patients Undergoing Total Hip Arthroplasty

2017Econometric modelling of multiple self-reports of health states: The switch from EQ-5D-3L to EQ-5D-5L in evaluating drug therapies for rheumatoid arthritis